V. Alfaro

Human autologous serum for the treatment of full-thickness macular holes. A preliminary study.

W. Mieler, B. Horio, P. Liggett, 1995, Ophthalmology.

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.

Arthur D. Fu, Ajay E. Kuriyan, Rishi P. Singh, 2022, Lancet.

Preoperative use of tissue plasminogen activator for large submacular hemorrhage.

W. Mieler, D. Han, N. Chaudhry, 1999, Ophthalmic surgery and lasers.

Ranibizumab for diabetic retinopathy.

J. Kerrison, V. Alfaro, E. Jablon, 2009, Current diabetes reviews.